China National Biotech Group

18 articles about China National Biotech Group

• Croma Establishes New Joint Venture in China

  9/15/2020

  Austria-based medical aesthetic products’ manufacturer Croma-Pharma GmbH establishes new Joint Venture with China National Biotech Group Company Ltd. to market its premium Hyaluronic Acid Filler Princess® VOLUME and various additional aesthetic products of Croma in China and Hong Kong.

• China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization

  10/9/2013

• Hua Han Bio-Pharma and China National Biotech Group Announce JV

  4/23/2013

• China National Biotech Group's $1.5 Billion IPO is Rumored Again

  1/15/2013

• China National Biotech Group May Soon Sell Vaccine to International Aid Groups

  10/5/2012

• Week in Review: China National Biotech Group Plans $1.6 Billion Hong Kong IPO

  9/10/2012

• China National Biotech Group Approved for $1.6 Billion Hong Kong IPO

  9/6/2012

• China National Biotech Group Institute Buys Vaccine Conjugate Technology From FinaBio

  8/21/2012

• China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO

  5/18/2012

• Aeras and China National Biotech Group Partner on TB Vaccine

  1/10/2012

• The Week in Review: China National Biotech Group Schedules $2 Billion IPO in Hong Kong

  11/14/2011

• China National Biotech Group's Hong Kong IPO to Raise Up to $2 Billion

  11/9/2011

• China National Biotech Group to IPO on the Hong Kong Exchange

  11/7/2011

• Immunobiology Limited (ImmBio) Strikes China Deal with China National Biotech Group Unit for TB Vaccine

  11/4/2011

• Aeras and China National Biotech Group Sign MOU for TB Vaccine

  7/26/2011

• Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration

  7/26/2011

• China National Biotech Group Given Go-Ahead to Test HFMD Vaccine

  12/28/2010

• China National Biotech Group to Invest Over $263 Million in Diagnostic Reagent Production Base in Jilin

  8/13/2007